Lich, October. 14th 2020 – To enable an even more efficient sample throughput, BAG Diagnostics GmbH has perfected its well-established real-time PCR kit for the detection of SARS-CoV-2: With ViroQ Rapid SARS-CoV-2, valid results are now available after less than 60 minutes instead of 90 minutes. The optimized PCR protocol enables laboratories can to evaluate an entire test run more per day.
The increasing number of people infected with the corona virus worldwide requires a high volume of reliable rapid tests. In order to deliver valid results quickly, the established German company BAG Diagnostics has optimized the PCR protocol of the certified rapid test ViroQ SARS-CoV-2. With ViroQ Rapid SARS-CoV-2, laboratories can now make statements on the available sample material in less than 60 minutes.
Fast One-Step Real-time PCR
ViroQ Rapid SARS-CoV-2 is designed for the specific detection of the viral RNA genes E and RdRP of SARS-CoV-2 from throat/nose swabs. In the test kit the RNA is transcribed from SARS-CoV-2 (COVID-19) to cDNA in the first step of the PCR protocol. This cDNA is amplified in the same, now optimized real-time PCR protocol. The modified PCR protocol is applicable to both kit variants of ViroQ. The fluorescent dyes used are compatible with the common real-time cyclers. Therefore, laboratories remain independent from dedicated providers.
Cell material check for valid test results
The tapping of tracheal secretion and sputum is a difficult procedure: If one proceeds too forcefully, blood impurities can worsen the performance. If you are too reluctant, you will get an inadequate tap with too less cell material. To make sure that there is enough cell material for a detection, the ViroQ Rapid SARS-CoV-2 Kit checks whether a human gene that is universally existing in cells is present in sufficient quantity. The PCR test excludes false negative results caused by insufficient samples.
No cooling for transport
The ViroQ Rapid SARS-CoV-2 test kits – just like the ViroQ SARS-CoV-2 variant – can be shipped uncooled. A control temperature of -20 degrees Celsius is only necessary for storage.
The test is available immediately. Detailed information: https://www.bag-diagnostics.com
This text has 2,271 characters including spaces. Further information and a wide variety of images are available in electronic form at email@example.com. A specimen copy to the agency is requested.
BAG Diagnostics GmbH
Dr. Ingo D. Meier
Fon: +49 6404 / 925-31
Satzanfang – Kommunikation & PR
Fon: + 49 45 02/ 76 59-742
BAG Diagnostics GmbH, which is part of BAG Holding, is a traditional family business of the Sachsenberg family, which was founded in 1947 by Gotthard Sachsenberg. Dr. med. Nicolas Sachsenberg is the 3rd generation of the Sachsenberg family to direct the fortunes of BAG. The success story began with development laboratories in the rooms of Solms' castle in Lich, Hesse.
Today BAG is a worldwide operating company for health care products for safe medical treatment. It develops, produces and distributes in-vitro diagnostics based on the latest research. As a pharmaceutical contract manufacturer, BAG Health Care is specialized in the production of parenteralia and lyopiylisates.